Caseware UK (AP4) 2022.0.179 2022.0.179 2022-12-312022-12-31true50truetruetruetruetruetruetrue2022-01-01falseNo description of principal activity42 10055682 2022-01-01 2022-12-31 10055682 2021-01-01 2021-12-31 10055682 2022-12-31 10055682 2021-12-31 10055682 2021-01-01 10055682 2 2022-01-01 2022-12-31 10055682 2 2021-01-01 2021-12-31 10055682 7 2022-01-01 2022-12-31 10055682 7 2021-01-01 2021-12-31 10055682 1 2022-01-01 2022-12-31 10055682 e:Director1 2022-01-01 2022-12-31 10055682 e:Director6 2022-01-01 2022-12-31 10055682 e:RegisteredOffice 2022-01-01 2022-12-31 10055682 d:Buildings d:ShortLeaseholdAssets 2022-01-01 2022-12-31 10055682 d:Buildings d:ShortLeaseholdAssets 2022-12-31 10055682 d:Buildings d:ShortLeaseholdAssets 2021-12-31 10055682 d:FurnitureFittings 2022-01-01 2022-12-31 10055682 d:FurnitureFittings 2022-12-31 10055682 d:FurnitureFittings 2021-12-31 10055682 d:FurnitureFittings d:OwnedOrFreeholdAssets 2022-01-01 2022-12-31 10055682 d:ComputerEquipment 2022-01-01 2022-12-31 10055682 d:ComputerEquipment 2022-12-31 10055682 d:ComputerEquipment 2021-12-31 10055682 d:ComputerEquipment d:OwnedOrFreeholdAssets 2022-01-01 2022-12-31 10055682 d:OtherPropertyPlantEquipment 2022-01-01 2022-12-31 10055682 d:OtherPropertyPlantEquipment 2022-12-31 10055682 d:OtherPropertyPlantEquipment 2021-12-31 10055682 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2022-01-01 2022-12-31 10055682 d:OwnedOrFreeholdAssets 2022-01-01 2022-12-31 10055682 d:CurrentFinancialInstruments 2022-12-31 10055682 d:CurrentFinancialInstruments 2021-12-31 10055682 d:Non-currentFinancialInstruments 2022-12-31 10055682 d:Non-currentFinancialInstruments 2021-12-31 10055682 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 10055682 d:CurrentFinancialInstruments d:WithinOneYear 2021-12-31 10055682 d:Non-currentFinancialInstruments d:AfterOneYear 2022-12-31 10055682 d:Non-currentFinancialInstruments d:AfterOneYear 2021-12-31 10055682 d:ReportableOperatingSegment1 2022-01-01 2022-12-31 10055682 d:ReportableOperatingSegment1 2021-01-01 2021-12-31 10055682 d:ReportableOperatingSegment7 2022-01-01 2022-12-31 10055682 d:ReportableOperatingSegment7 2021-01-01 2021-12-31 10055682 d:UKTax 2022-01-01 2022-12-31 10055682 d:UKTax 2021-01-01 2021-12-31 10055682 d:ShareCapital 2022-01-01 2022-12-31 10055682 d:ShareCapital 2022-12-31 10055682 d:ShareCapital 2021-01-01 2021-12-31 10055682 d:ShareCapital 2021-12-31 10055682 d:ShareCapital 2021-01-01 10055682 d:SharePremium 2022-01-01 2022-12-31 10055682 d:SharePremium 2022-12-31 10055682 d:SharePremium 2 2022-01-01 2022-12-31 10055682 d:SharePremium 2021-01-01 2021-12-31 10055682 d:SharePremium 2021-12-31 10055682 d:SharePremium 2021-01-01 10055682 d:SharePremium 2 2021-01-01 2021-12-31 10055682 d:CapitalRedemptionReserve 2022-01-01 2022-12-31 10055682 d:CapitalRedemptionReserve 2022-12-31 10055682 d:CapitalRedemptionReserve 2 2022-01-01 2022-12-31 10055682 d:CapitalRedemptionReserve 2021-01-01 2021-12-31 10055682 d:CapitalRedemptionReserve 2021-12-31 10055682 d:CapitalRedemptionReserve 2021-01-01 10055682 d:CapitalRedemptionReserve 2 2021-01-01 2021-12-31 10055682 d:RetainedEarningsAccumulatedLosses 2022-01-01 2022-12-31 10055682 d:RetainedEarningsAccumulatedLosses 2022-12-31 10055682 d:RetainedEarningsAccumulatedLosses 2 2022-01-01 2022-12-31 10055682 d:RetainedEarningsAccumulatedLosses 2021-01-01 2021-12-31 10055682 d:RetainedEarningsAccumulatedLosses 2021-12-31 10055682 d:RetainedEarningsAccumulatedLosses 2021-01-01 10055682 d:RetainedEarningsAccumulatedLosses 2 2021-01-01 2021-12-31 10055682 e:FRS101 2022-01-01 2022-12-31 10055682 e:Audited 2022-01-01 2022-12-31 10055682 e:FullAccounts 2022-01-01 2022-12-31 10055682 e:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 10055682 e:SmallCompaniesRegimeForAccounts 2022-01-01 2022-12-31 10055682 2 2022-01-01 2022-12-31 10055682 d:CurrentFinancialInstruments 7 2022-12-31 10055682 d:CurrentFinancialInstruments 7 2021-12-31 10055682 d:PriorPeriodErrorIncreaseDecrease 2021-01-01 2021-12-31 10055682 d:ShareCapital d:PriorPeriodErrorIncreaseDecrease 2021-01-01 2021-12-31 10055682 d:SharePremium d:PriorPeriodErrorIncreaseDecrease 2021-01-01 2021-12-31 10055682 d:CapitalRedemptionReserve d:PriorPeriodErrorIncreaseDecrease 2021-01-01 2021-12-31 10055682 d:RetainedEarningsAccumulatedLosses d:PriorPeriodErrorIncreaseDecrease 2021-01-01 2021-12-31 iso4217:GBP xbrli:pure
Registered number: 10055682 (England and Wales)














IRHYTHM TECHNOLOGIES LTD.

DIRECTORS' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2022


 
IRHYTHM TECHNOLOGIES LTD.
 

 
COMPANY INFORMATION


Directors
P M Murphy 
B A Bobzien 




Registered number
10055682



Registered office
Seal House
56 London Rd

Bagshot

United Kingdom

GU19 5HL




Independent auditors
ZEDRA Corporate Reporting Services (UK) Limited






 
IRHYTHM TECHNOLOGIES LTD.
 


CONTENTS



Page
Statement of Financial Position
 
1 - 2
Statement of Changes in Equity
 
3
Notes to the Financial Statements
 
4 - 14



 
IRHYTHM TECHNOLOGIES LTD.
REGISTERED NUMBER:10055682


STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2022

2022
2021
Note
£
£

Fixed assets
  

Tangible fixed assets
 9 
575,601
672,500

  
575,601
672,500

Current assets
  

Debtors: amounts falling due within one year
 10 
2,445,985
842,389

Bank and cash balances
  
2,735,770
2,644,620

  
5,181,755
3,487,009

Creditors: amounts falling due within one year
 11 
(2,530,487)
(1,792,418)

Net current assets
  
 
 
2,651,268
 
 
1,694,591

Total assets less current liabilities
  
3,226,869
2,367,091

Creditors: amounts falling due after more than one year
 12 
(510,951)
(591,898)

  

Net assets
  
2,715,918
1,775,193

Page 1


 
IRHYTHM TECHNOLOGIES LTD.
REGISTERED NUMBER:10055682

    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2022

2022
2021
Note
£
£

Capital and reserves
  

Called up share capital 
  
1,000
1,000

Share premium account
 13 
19,167
19,167

Capital contribution reserve
 13 
1,368,882
794,283

Profit and loss account
 
1,326,869
960,743

  
2,715,918
1,775,193


The Company's financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 

B A Bobzien
Director

Date: 8 March 2024

Page 2


 
IRHYTHM TECHNOLOGIES LTD.
 


STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2022


Called up share capital
Share premium account
Capital contribution reserve
Profit and loss account
Total equity

£
£
£
£
£


At 1 January 2021 (as previously stated)
1,000
19,167
509,085
753,300
1,282,552

Prior year adjustment
-
-
-
(147,447)
(147,447)


At 1 January 2021 (as restated)
1,000
19,167
509,085
605,853
1,135,105



Profit for the year (as restated)
-
-
-
354,890
354,890
Total comprehensive income for the year
-
-
-
354,890
354,890

Share based payment
-
-
285,198
-
285,198



At 1 January 2022
1,000
19,167
794,283
960,743
1,775,193



Profit for the year
-
-
-
366,126
366,126
Total comprehensive income for the year
-
-
-
366,126
366,126

Share based payment
-
-
574,599
-
574,599


At 31 December 2022
1,000
19,167
1,368,882
1,326,869
2,715,918


Page 3


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

1.


General information

iRhythm Technologies Ltd. is a private company, limited by shares, incorporated in England. The registered office can be found on the company information page.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 101 'Reduced Disclosure Framework'  and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 101 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies (see note 4).

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 101 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions under FRS 101:
the requirements of paragraphs 45(b) and 46-52 of IFRS 2 Share-based payment
the requirements of IFRS 7 Financial Instruments: Disclosures
the requirement in paragraph 38 of IAS 1 'Presentation of Financial Statements' to present comparative information in respect of:
 - paragraph 79(a)(iv) of IAS 1;
the requirements of paragraphs 10(d), 10(f), 16, 38A, 38B, 38C, 38D, 40A, 40B, 40C, 40D, 111 and 134-136 of IAS 1 Presentation of Financial Statements
the requirements of IAS 7 Statement of Cash Flows
the requirements of paragraph 17 and 18A of IAS 24 Related Party Disclosures
the requirements in IAS 24 Related Party Disclosures to disclose related party transactions entered into between two or more members of a group, provided that any subsidiary which is a party to the transaction is wholly owned by such a member

This information is included in the consolidated financial statements of iRhythm Technologies, Inc. as at 31 December 2022 and these financial statements may be obtained from www.sec.gov.

  
2.3

Going concern

The Company is in a net asset position of £2,715,918 (2021: £1,775,193) at the balance sheet date, supported by significant cash reserves. The Company has received written confirmation from its parent company, iRhythm Technologies, Inc., that it will continue to provide financial support for a period of at least 12 months from the date of signing these financial statements. For these reasons, the directors continue to adopt the going concern basis in preparing the financial statements.

Page 4


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)

 
2.4

Turnover

Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Rendering of services

The Company's turnover is derived from the provision of digital healthcare services to its customers.
Turnover is recognised as services are used by the customer. Turnover can only be recognised when each of the following criteria are met:

the amount of turnover can be measured reliably;

it is probable that the Company will receive the consideration due under the contract

The Company also recharges its expenditure to its parent company iRhythm Technologies, Inc., in accordance with an intercompany services agreement.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Page 5


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)

 
2.6

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.

 
2.7

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.8

Interest income

Interest income is recognised in profit or loss using the effective interest method.

  
2.9

Share based payments

Certain employees of the Company are entitled to stock option grants, Restricted Stock Units ("RSUs") and shares under the Employee Stock Purchase Programme ("ESPP") in iRhythm Technologies, Inc., the parent company. The share options and ESPP shares are granted at an independently determined fair value using the Black-Scholes option pricing model. The RSU shares are valued at the fair value at the grant date. Shares granted under the 2016 Equity Incentive Plan are granted at a price of not less than 100% of the fair market value of the common stock at the date of grant. Shares granted under the Employee Stock Purchase Plan are discounted at a rate of 85% of the lower of the fair market value of the Company's common stock on the first date of the offering period or on the last day of the purchase period as defined in the terms of the agreement.
An expense equivalent to the fair value of the share options granted is recognised evenly over the vesting period, with a corresponding amount being recognised in the capital contribution reserve.

Page 6


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)

 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

The estimated useful lives range as follows:

Short-term leasehold improvements
-
3 years
Fixtures and fittings
-
5 years
Right-of-use asset
-
Life of the lease

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Debtors

Short term debtors are measured at transaction price, less any impairments. Amounts owed by group undertakings are intercompany loans which are repayable on demand, no interest is charged on these loans.

 
2.12

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash held on deposit by service providers is included within bank and cash balances, as these amounts are highly liquid and repayable without penalty on notice of not more than 24 hours.

 
2.13

Creditors

Creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Creditors are recognised initially at fair value and subsequently measured at amortised cost using the effective interest method.

Page 7


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)

 
2.14

Leases

The Company as a lessee

The Company assesses whether a contract is or contains a lease, at inception of a contract. The Company recognises a right-of-use asset and a corresponding lease liability with respect to all lease agreements in which it is the lessee, except for short-term leases (defined as leases with a lease term of 12 months or less) and leases of low value assets. For these leases, the Company recognises the lease payments as an operating expense on a straight-line basis over the term of the lease unless another systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by using the rate implicit in the lease. If this rate cannot be readily determined, the Company uses its incremental borrowing rate, 4.75%. This rate has been based on the incremental borrowing rate obtained by the parent company.

Lease payments included in the measurement of the lease liability comprise:

variable lease payments that depend on an index or rate, initially measured using the index or rate at the commencement date;


The lease liability is included in 'Creditors' on the Statement of Financial Position.

The lease liability is subsequently measured by increasing the carrying amount to reflect interest on the lease liability (using the effective interest method) and by reducing the carrying amount to reflect the lease payments made.

The right-of-use assets comprise the initial measurement of the corresponding lease liability, lease payments made at or before the commencement day and any initial direct costs. They are subsequently measured at cost less accumulated depreciation and impairment losses.

Right-of-use assets are depreciated over the shorter period of lease term and useful life of the underlying asset. If a lease transfers ownership of the underlying asset or the cost of the right-of-use asset reflects that the Company expects to exercise a purchase option, the related right-of-use asset is depreciated over the useful life of the underlying asset. The depreciation starts at the commencement date of the lease.

The right-of-use assets are included in the Tangible Fixed Assets as applicable, in the Statement of Financial Position.

The Company applies IAS 36 to determine whether a right-of-use asset is impaired and accounts for any identified impairment loss as described in note 2.10.

As a practical expedient, IFRS 16 permits a lessee not to separate non-lease components, and instead account for any lease and associated non-lease components as a single arrangement. The Company has not used this practical expedient.

  
2.15

VAT recoverable

VAT recovered from restrospective claims made to HMRC during the period and recognised as other operating income.

Page 8


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

3.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2022 was unqualified.

The audit report was signed on 8 March 2024 by Dominic King ACA (Senior Statutory Auditor) on behalf of ZEDRA Corporate Reporting Services (UK) Limited.


4.


Judgements in applying accounting policies and key sources of estimation uncertainty

The preparation of financial statements requires management to make judgements, estimates and assumptions that affect the application of policies and recorded amount of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form a basis for making judgements about the carrying value of assets and liabilities that are not readily apparent from other sources.
Incremental borrowing rate
In accordance with IFRS 16, management have been required to assess the time value of money in relation to long term liabilities. As a result, 4.75% has been identified as the Company's incremental borrowing rate, which has been based on the incremental borrowing rate obtained by the parent company, in connection with its Loan and Security Agreement with Silicon Valley Bank.


5.


Turnover

An analysis of turnover by class of business is as follows:


2022
2021
£
£

Digital healthcare services
4,234,184
3,564,902

Intercompany sales
6,164,183
4,969,670

10,398,367
8,534,572


All digital healthcare service sales arose within the United Kingdom and the intercompany sales arose in accordance with the intercompany services agreement with the parent company, iRhythm Technologies, Inc., a company incorporated in the United States.


6.


Operating profit

The operating profit is stated after charging:

2022
2021
£
£

Depreciation of tangible fixed assets
106,101
97,134

Exchange differences
275,534
3,413

Share-based payments
407,060
337,482

Page 9


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

7.


Employees

2022
2021
£
£

Wages and salaries
3,798,198
3,974,854

Social security costs
697,557
584,732

Cost of defined contribution scheme
173,838
162,244

4,669,593
4,721,830


The average monthly number of employees, including the directors, during the year was as follows:


        2022
        2021
            No.
            No.







Employees
50
42

Page 10


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

8.


Taxation


2022
2021
£
£

Corporation tax


Current tax on profits for the year
87,810
110,237

Total current tax
87,810
110,237

Deferred tax

Taxation on profit on ordinary activities
 
87,810
 
110,237

Factors affecting tax charge for the year

The tax assessed for the year is higher than (2021 - higher than) the standard rate of corporation tax in the UK of 19% (2021 - 19%). The differences are explained below:

2022
2021
£
£


Profit on ordinary activities before tax
453,936
465,127


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 19% (2021 - 19%)
86,248
88,374

Effects of:


Expenses not deductible for tax purposes
14,196
76,296

Capital allowances
(15,008)
(1,969)

Adjustments to tax charge in respect of prior periods
-
9,475

Short term timing difference leading to an increase (decrease) in taxation
1,692
-

Tax deduction arising from exercise of employee options
682
(58,633)

Other differences leading to an increase (decrease) in the tax charge
-
(3,306)

Total tax charge for the year
87,810
110,237


Factors that may affect future tax charges

On 24 May 2021, Finance Bill 2021 was substantively enacted. The result of this is that the main rate of corporation tax for the UK has increased to 25% from 1 April 2023.

Page 11


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

9.


Tangible fixed assets





Short-term leasehold property
Fixtures and fittings
Computer equipment
Right-of-use asset
Total

£
£
£
£
£



Cost or valuation


At 1 January 2022
14,285
52,748
-
714,084
781,117


Additions
-
-
9,202
-
9,202



At 31 December 2022

14,285
52,748
9,202
714,084
790,319



Depreciation


At 1 January 2022
8,333
18,462
-
81,822
108,617


Charge for the year on owned assets
4,762
10,550
1,880
88,909
106,101



At 31 December 2022

13,095
29,012
1,880
170,731
214,718



Net book value



At 31 December 2022
1,190
23,736
7,322
543,353
575,601



At 31 December 2021
5,952
34,286
-
632,262
672,500


10.


Debtors

2022
2021
£
£


Amounts owed by group undertakings
2,125,805
618,304

Other debtors
56,076
69,232

Prepayments and accrued income
264,104
154,853

2,445,985
842,389


Page 12


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

11.


Creditors: Amounts falling due within one year

2022
2021
£
£

Trade creditors
62,741
48,016

Corporation tax
148,700
112,282

Other taxation and social security
1,382,480
940,515

Lease liabilities
78,616
65,133

Accruals and deferred income
857,950
626,472

2,530,487
1,792,418




12.


Creditors: Amounts falling due after more than one year

2022
2021
£
£

Lease liabilities
510,951
591,898

510,951
591,898



13.


Reserves

Share premium account

The share premium account represents the excess of the issue price over the par value on shares issued less transaction costs arising on issue. 

Capital contribution reserve

Certain employees of the Company have been granted options to purchase shares or granted Restricted Stock Units in iRhythm Technologies, Inc., the parent company. The share options and RSUs are granted at an independently determined fair value.
An expense equivalent to the fair value of the share options granted is recognised evenly over the vesting period, four years, with a corresponding amount being recognised in the capital contribution reserve.
On forfeiture or cancellation of an individual's share based payments, vesting is stopped and outstanding shares are transferred from the capital contribution reserve to the profit and loss reserve.

Page 13


 
IRHYTHM TECHNOLOGIES LTD.
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

14.

Leases

Company as a lessee

The Company leases its office space and is capitalised in accordance with IFRS 16. 
The Company entered into a new lease in January 2021 for a minimum period of three years.


The following amounts in respect of leases, where the Company is a lessee, have been recognised in profit or loss:

2022
2021
£
£

Interest on lease liabilities (IFRS 16)
29,686
27,670

Depreciation charge on right-of-use assets
88,909
81,822


15.


Controlling party

iRhythm Technologies, Inc., is the parent of the smallest group for which consolidated financial statements are drawn up of which the Company is a member. The registered office of the parent company is 699 8th Street, Suite 600, San Francisco, CA 94103.


16.


Post balance sheet events

During 2023, a Swiss branch of the UK entity was incorporated. Three employees were hired on 1 October 2023, however there has not been any significant financial activity during the year.
There were no adjusting or other non-adjusting events occurring between the end of the reporting period and the date these financial statements were approved.

 
Page 14